000 01549 a2200373 4500
005 20250516021826.0
264 0 _c20110606
008 201106s 0 0 eng d
022 _a1557-7732
024 7 _a10.1089/jop.2010.0109
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLanda, Gennady
245 0 0 _aQualitative spectral OCT/SLO analysis of drusen change in dry age-related macular degeneration patients treated with Copaxone.
_h[electronic resource]
260 _bJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
_cFeb 2011
300 _a77-82 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aGlatiramer Acetate
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMacular Degeneration
_xcomplications
650 0 4 _aPeptides
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aRetinal Drusen
_xdiagnosis
650 0 4 _aTomography, Optical Coherence
_xmethods
700 1 _aRosen, Richard B
700 1 _aPatel, Amar
700 1 _aLima, Veronica Castro
700 1 _aTai, Katy W
700 1 _aPerez, Violete R
700 1 _aAizman, Alexander
700 1 _aGarcia, Patricia M T
773 0 _tJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
_gvol. 27
_gno. 1
_gp. 77-82
856 4 0 _uhttps://doi.org/10.1089/jop.2010.0109
_zAvailable from publisher's website
999 _c20536104
_d20536104